|
PARP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.52859980018638E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.56230000550417E-08 |
| Normal-vs-Stage2 |
2.612600E-04 |
| Normal-vs-Stage3 |
4.153900E-04 |
| Normal-vs-Stage4 |
3.125600E-02 |
| Stage1-vs-Stage2 |
2.567000E-01 |
| Stage1-vs-Stage3 |
8.191200E-01 |
| Stage1-vs-Stage4 |
8.234600E-01 |
| Stage2-vs-Stage3 |
2.385000E-01 |
| Stage2-vs-Stage4 |
3.529400E-01 |
| Stage3-vs-Stage4 |
9.370400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.43739994643511E-09 |
| Normal-vs-AfricanAmerican |
2.94400000044881E-07 |
| Normal-vs-Asian |
7.583100E-03 |
| Caucasian-vs-AfricanAmerican |
3.937600E-01 |
| Caucasian-vs-Asian |
8.030800E-01 |
| AfricanAmerican-vs-Asian |
6.038800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.03210045749358E-10 |
| Normal-vs-Female |
4.68079999982329E-07 |
| Male-vs-Female |
7.936200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.097000E-03 |
| Normal-vs-Extreme_Weight |
9.17509999975863E-07 |
| Normal-vs-Obese |
1.51689999450255E-08 |
| Normal-vs-Extreme_Obese |
1.032950E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.934380E-01 |
| Normal_Weight-vs-Obese |
1.162180E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.539200E-01 |
| Extreme_Weight-vs-Obese |
9.880300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.869200E-01 |
| Obese-vs-Extreme_Obese |
2.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.102200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.08250092118101E-11 |
| Normal-vs-Age(61-80Yrs) |
4.8882000003303E-07 |
| Normal-vs-Age(81-100Yrs) |
4.884500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.131000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.126400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.981800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.551990E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.274210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.432800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99520000521147E-09 |
| Normal-VS-Type2 PRCC |
1.19310000001871E-06 |
| Normal-VS-KIRP CIMP |
1.212130E-02 |
| Normal-VS-Unclassified PRCC |
2.20630000002942E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.126400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.148400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.170400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.020200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.031700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.425970E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.5942000000051E-05 |
| Normal-vs-N1 |
3.63449999996046E-06 |
| Normal-vs-N2 |
2.602200E-01 |
| N0-vs-N1 |
5.819000E-01 |
| N0-vs-N2 |
4.564200E-01 |
| N1-vs-N2 |
1.984590E-01 |
|
|
